Zydus

DCGI approves emergency use of Zydus’s Virafin

Zydus Cadila received emergency use approval from the Drugs Controller General of India (DCGI) for the use of Virafin, Pegylated Interferon alpha- 2b(PegIFN) in treating moderate COVID-19COVID-19 infection in adults. infection in adults. A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients.  As per the release, …

DCGI approves emergency use of Zydus’s Virafin Read More »